ArticlePDF AVAILABLE

Correspondence COVID-19: Melatonin as a potential adjuvant treatment

Life Sciences
DOI: 10.1016/j.lfs.2020.117716
10Citations
Citations of this article
83Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Cite

CITATION STYLE

APA

Salles, C. (2020, July 15). Correspondence COVID-19: Melatonin as a potential adjuvant treatment. Life Sciences. Elsevier Inc. https://doi.org/10.1016/j.lfs.2020.117716

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free